Picture of Larimar Therapeutics logo

LRMR — Larimar Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapMomentum Trap

Brief: Larimar Therapeutics Q2 Net Income USD -21.627 Million

Aug 07 (Reuters) - Larimar Therapeutics Q2 basic EPS USD -0.34.
* Q2 operating expenses USD 24.599 million
* Q2 income from operations USD -24.599 million

Recent news on Larimar Therapeutics

See all news